About Us

Over three decades of dedication to improving pharmaceutical access across Nigeria and sub-Saharan Africa.

Dr Sam Olawoye, Founder of Sam-Ace Limited

Dr Sam Olawoye

Founder & CEO

40+

Years Experience

Our Founder

The Vision Behind Sam-Ace

Dr Sam Olawoye is the visionary founder of Sam-Ace Limited. A distinguished pharmacy graduate, he has dedicated over 40 years to improving pharmaceutical access across Nigeria and the broader African continent.

He holds a PhD in Pharmaceutical Chemistry from Obafemi Awolowo University (OAU), Ile-Ife, and is a Fellow of the West African Post Graduate College of Pharmacy — a testament to his deep commitment to academic and professional excellence in pharmaceutical sciences.

Starting with a single retail pharmacy in Kano in 1991, Dr Olawoye's ambition to manufacture quality, affordable medicines led to the establishment of the Sam-Ace manufacturing arm in 2003. Today, his company produces NAFDAC-registered, WHO-listed essential medicines that serve patients across Nigeria.

PhD

Pharmaceutical Chemistry, OAU

Fellow

West African Post Graduate College of Pharmacy

40+ Years

Pharmaceutical Experience

Vision & Mission

Our Vision

Sub-Saharan Africa's Leading Antibiotic Manufacturer

To become a leading provider of beta lactam antibiotics in sub-Saharan Africa, ensuring every patient has access to safe, affordable, effective medicines.

Our Mission

Improving Access to Quality Medicines

To improve access to quality medicines across sub-Saharan Africa through ethical manufacturing, rigorous quality control, and patient-centred innovation.

Our Journey

Three Decades of Growth

Foundation

Sam-Ace Limited started as a retail pharmacy in Kano, Nigeria, laying the groundwork for decades of pharmaceutical excellence.

1991

Manufacturing Begins

Entered pharmaceutical manufacturing, marking a pivotal shift from retail to becoming a quality medicine producer.

2003

NAFDAC Registration

Received NAFDAC registration for ORS®, the Oral Rehydration Salt product that became a cornerstone of the portfolio.

2005

Antibiotic Expansion

Expanded into dry syrup beta lactam antibiotics. Registered ASTAPICIN®, ASTARCLOX®, and ASTAMOCIL® — broadening access to essential medicines.

2006

Land Acquisition

Acquired land in Osun State, Nigeria, to support ambitious plans for a modern, GMP-compliant manufacturing facility.

2008

Osun State HQ

Relocated and commenced operations at Km 14, Gbongan-Ibadan Road, Akoda-Ede, Osun State — establishing the current manufacturing hub.

2010

Capsule Line Launch

Added a dedicated capsule production line; registered ASTARCLOX® and ASTAMOCIL® capsule formulations for adult patients.

2013

Tablet Line & ASTAMENTIN®

Added a tablet manufacturing line and registered ASTAMENTIN® in both dry syrup and tablet forms, completing the pediatric and adult antibacterial portfolio.

2017

New Facility Land

Acquired additional land to accommodate a state-of-the-art beta lactam antibiotic manufacturing facility to meet growing sub-Saharan African demand.

2020

Strategic Partnership

Entered a landmark partnership agreement with a consortium of investors and experts in pharmaceutical materials, equipment procurement, logistics, and sales.

2021

New Facility Operational

Completed construction and commenced full operations at the new beta lactam antibiotics facility — a milestone cementing Sam-Ace's position as a leading Nigerian pharma manufacturer.

2024
What Drives Us

Our Core Values

Performance

We set high standards and consistently deliver products that exceed regulatory requirements and patient expectations.

Integrity

Every decision is guided by transparency, ethical practice, and unwavering honesty with our stakeholders.

Leadership

We take initiative, inspire others, and drive innovation that positions Sam-Ace as a sector pioneer.

Teamwork

Collaboration across every department and partnership creates the strength behind our mission to improve lives.

Excellence

A relentless pursuit of quality in manufacturing, compliance, customer service, and continuous improvement.